JAMA Editors' Summary cover image

Sacubitril/Valsartan and Heart Failure, Prior SARS-CoV-2 Infection and Breakthrough Infection Following mRNA Vaccination, COVID-19 and In-Hospital Mortality With Myocardial Infarction, and more

JAMA Editors' Summary

00:00

Introduction

This is the jama editor's summary, a review of important research and review articles appearing in the latest jama issue. The parallax randomized clinical trial found that secubitre val sartan significantly reduced nt probian p levels compared with standard therapes. This therap did not significantly increase six minute walking distance or the kansas city cardimaopathy questionair summary score which is a measure of quality of life.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app